| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Nyxoid 1,8 mg, Nasenspray | | 66930 | | 01 | | Nyxoid 1,8 mg | | Nasenspray | | V03AB15 | | Naloxon | | 12.07.2018 | | |
| | Zusammensetzung | | naloxoni hydrochloridum dihydricum 2.2 mg corresp. naloxoni hydrochloridum anhydricum 2 mg corresp. naloxonum 1.8 mg, trinatrii citras dihydricus, natrii chloridum, acidum hydrochloridum concentratum q.s. ad pH, natrii hydroxidum q.s. ad pH, nitrogenia q.s., aqua purificata q.s. ad solutionem, solutio 100 µl et propellentia ad aerosolum corresp. natrium 0.14 mg. | | Packungsbestandteile | | Nasenspray | | | | | | | | | Hilfsstoffe | Stärke |
|---|
| | | | Naloxoni Hydrochloridum Dihydricum | 2.2 mg | | Natrii Chloridum | | | | |
|
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 001 | 2 | PA | PA | B | | Ja |
|
|
